Advertisement
Catch up with our latest volumes and outcomes data
Below we share recent volumes and clinical outcomes from a sampling of areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation and two unique populations — patients with hypertrophic obstructive cardiomyopathy and patients with pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2022):
Of 103 rated participants in this STS category, Cleveland Clinic was 1 of 15 that achieved a 3-star (highest) rating.
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent
Understanding TE involvement is a key to developing new treatments
How nurses can effect change through professional writing
Nurses who embrace innovation can solve problems and improve healthcare for patients and caregivers
Study finds important discrepancies among modalities and techniques
Serial strain assessments show sustained favorable impacts on LV systolic function and LA function
Our latest volumes and outcomes data in these areas plus HOCM and pericarditis
Exploring the cost-effectiveness of end-of-life treatment options